Investor Relations Marrone Bio Innovations Inc. is now part of Bioceres Crop Solutions (NASDAQ: BIOX). Learn MorePress Releasesview all Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp.July 11, 2022Press Releases Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial ResultsMay 11, 2022Press Releases Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern TimeApril 27, 2022Press Releases Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial ResultsMarch 28, 2022Press Releases Marrone Bio Expands Biological Seed Treatment Collaboration for Row CropsMarch 24, 2022Press Releases Bioceres Crop Solutions and Marrone Bio Announce Merger AgreementMarch 16, 2022Press Releases Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp.July 11, 2022Press Releases Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial ResultsMay 11, 2022Press Releases Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern TimeApril 27, 2022Press Releases Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial ResultsMarch 28, 2022Press Releases Marrone Bio Expands Biological Seed Treatment Collaboration for Row CropsMarch 24, 2022Press Releases Bioceres Crop Solutions and Marrone Bio Announce Merger AgreementMarch 16, 2022Press Releases Presentations & Interviewsview all May 11, 2022MBII 2022 First Quarter Earnings Call Slides April 1, 2022Investor Primer – March 2022 See Presentations Library for more. Settlement of Shareholder Derivative Lawsuits Notice of Pendency of Proposed Settlement of Stockholder Derivative Action Stipulation of Settlement
